Morgan Stanley expects US healthcare stocks to rebound strongly, citing sector catalysts, major investments by Eli Lilly and AstraZeneca, tariff protection, AI adoption, and a 30% valuation discount to the S&P 500.
#YonhapInfomax #MorganStanley #HealthcareStocks #SP500 #EliLilly #AstraZeneca #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=88849
#YonhapInfomax #MorganStanley #HealthcareStocks #SP500 #EliLilly #AstraZeneca #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=88849